The Clorox Company CLX

NYSE | Producer | Household and hygiene products
Follow The Clorox free Follow free

Email when the signal or risk changes · Sunday weekly brief

No card · No time limit on free tier · Upgrade when you need more

Updated: 4 Sep 2026 Base analysis: 31 Jul 2026

The news check keeps the assessment current.

General analysis — not personal advice.

HOLD Partly clear

Existing position can be maintained pending clearer margin trends.

Stable results with a marginal beat and defensive profile support a continued HOLD despite flat outlook and operational challenges.

Market sentiment Neutral →
Trend: Stable

Investors remain cautiously optimistic about margin recovery but concerned about operational challenges and the leadership transition.

Risk assessment High
Dilution: Low No share issuances reported, strong cash flows.
Jurisdiction: Low Primary operations in the US and developed markets.
Execution: High ERP disruptions and GOJO integration require continued focus.

HOLD is the call. Neutral is the market mood. High risk means a lot can go wrong.

About the company

The Clorox Company manufactures and sells consumer products in cleaning, disinfection and personal care. The company has a broad portfolio including Clorox, Glad, Brita, Burt's Bees and the recently acquired Purell. Operations are in a mature phase with focus on margin stability and operational efficiency.

Sector: Household and hygiene products
Type: Producer
Next report (Q1)
5 Nov 2026
Catalysts
◐
Oct 2026
New CEO appointment High
○
Q4 2026
GOJO integration update Medium
Bull case

Stable net earnings and defensive brands provide support even with flat organic growth.

Bear case

Flat FY2027 outlook and persistent cost pressure limit upside over the medium term.

Sensitivity analysis
Factor If it weakens If it strengthens
ERP implementation success Continued order fulfillment issues → lower volumes and weaker inventory management in coming quarters. Rapid supply chain normalization → higher sales and improved gross margin in H2 FY2026.
GOJO/Purell integration Higher than expected integration costs → pressure on net income and cash flow. Faster synergy realization → increased revenue growth in health and hygiene.
Why this signal

Stable results with a marginal beat and defensive profile support a continued HOLD despite flat outlook and operational challenges.

Recent news
  • The stock has fallen sharply after the report with unusually high volume on 31 August and closed at 94.29 USD on 3 September. GOJO integration continues as a key growth driver while ERP stabilization is expected to contribute positively in FY27.

Key figures

Revenue
Q4 2026
USD 2.0B
Revenue TTM
TTM
USD 6.9B
EBITDA
TTM
USD 1.1B
Net income
Q4 2026
USD 163M
Cash
Q1 2026
USD 1.2B
Total debt
Q1 2026
USD 4.5B
Gross margin
Q3 2026
43.2%
Shares outstanding
2026-01-20
121M
EPS
Q4 2026
USD 1.35
Exchange
NYSE
Type
Producer
Sector
Household and hygiene products
The Clorox Company CLX
The Clorox — this picture changes. Follow free
Follow The Clorox free Follow free
Firelda provides general information and analysis, not personal investment advice. Content does not consider your financial situation or goals. Investments can rise and fall in value. Always do your own research.